Research by scientists from the University of Duisburg-Essen (UDE) in western Germany has shown that a certain gene reduces the risk of death from the corona virus by 35 percent.
The study followed 1,570 patients who were diagnosed with the virus between May 11, 2020 and June 30, 2021, German University scientists announced.
A fifth of the patients who were investigated died
Thirteen percent or 205 of the study participants had only a mild form of the disease, 760 or 48 percent of them were hospitalized, and 292 or 19 percent of them ended up in the intensive care unit. A fifth or 313 patients whose disease development was monitored by the research died.
The gene that reduced the probability of death in some patients was called GNB3 TT. It is a variant that is estimated to be present in about ten percent of the European population. GNB3 is a gene that decodes the so-called G-proteins, important for a number of processes in the body.
One of the authors of the research: We discovered that the gene causes the activation of immune cells
The study also showed that the GNB3 gene causes the activation of immune cells, said one of the authors of the study, Birte Möhlendick.
This faster immune response may explain why the risk of death is so much lower for the group of people who carry this gene, explained Möhlendick.
The study confirmed the assumption that a younger age and the absence of chronic health problems, such as diabetes, significantly increase the chances that an individual will survive infection with the corona virus. The study, the results of which were published in the professional journal Frontiers in Genetics, did not monitor the behavior of omicrons.